Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TriMaster: Sitagliptin, Canagliflozin, and Pioglitazone in Type 2 Diabetes
NCT02653209Phase 4Completed
- Sponsor
- Royal Devon University Healthcare NHS Foundation Trust
- Start
- Nov 2016
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin, canagliflozin, pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Royal Devon University Healthcare NHS Foundation Trust. Started Nov 2016; status: completed.
02
Drugs
sitagliptincanagliflozinpioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02653209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653209.